Targeting reduction of proteinuria in glomerulonephritis: Maximizing the antifibrotic effect of valsartan by protecting podocytes.

Gu, Chunyan

Targeting reduction of proteinuria in glomerulonephritis: Maximizing the antifibrotic effect of valsartan by protecting podocytes. [electronic resource] - Journal of the renin-angiotensin-aldosterone system : JRAAS Jun 2014 - 177-89 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1752-8976

10.1177/1470320312466127 doi


Angiotensin II Type 1 Receptor Blockers--therapeutic use
Animals
Dose-Response Relationship, Drug
Fibrosis
Glomerulonephritis--complications
Intracellular Signaling Peptides and Proteins--biosynthesis
Kidney--pathology
Kidney Function Tests
Male
Membrane Proteins--biosynthesis
Podocytes--drug effects
Proteinuria--drug therapy
Rats
Rats, Sprague-Dawley
Tetrazoles--therapeutic use
Valine--analogs & derivatives
Valsartan